Persistence of activated anti-mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sameer,Mir

第一单位： Thoracic and GI Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA.

作者： Sameer,Mir ^[1] ; Abhilash,Venugopalan ^[1] ; Jingli,Zhang ^[1] ; Nishanth Ulhas,Nair ^[2] ; Manjistha,Sengupta ^[1] ; Manakamana,Khanal ^[1] ; Chaido,Stathopoulou ^[1] ; Qun,Jiang ^[1] ; Raffit,Hassan ^[1]

作者单位： Thoracic and GI Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA. ^[1] Cancer Data Science Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland, USA. ^[2]

关键词 CAR T cell anti‐PD1 colorectal cancer gastric cancer mesothelin pembrolizumab xenograft cancer model

主题词人类(Humans);胃肿瘤(Stomach Neoplasms);结直肠肿瘤(Colorectal Neoplasms);小鼠(Mice);动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);免疫疗法, 过继(Immunotherapy, Adoptive);GPI连接蛋白质类(GPI-Linked Proteins)

DOI 10.1002/ctm2.70057

PMID 39548594

发布时间 2024-11-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical and translational medicine

2024年14卷11期

e70057页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Persistence of activated anti-mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas.

Clinical and translational medicine

相似文献

Clinical and translational medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Persistence of activated anti-mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomas.

Clinical and translational medicine

相似文献

Clinical and translational medicine

相关期刊

检索历史清除